Similarly, IL-17A was overexpressed in 39% (8/10) of CRPC tissues, while CTSK was expressed only in 16% (5/10) of ADPC samples and in 8% (10/10) of BPH samples (Fig. 2E, F). Here, IL17A is linked to benign prostatic hyperplasia.